Shock, Cardiogenic: all 281 studies

Page 2 of 3. Open to participants first (128), then studies with results posted, then the rest; newest registration first within each.

• Pulmonary Artery Catheter in Cardiogenic Shock TrialRecruitingNCT05485376Not applicable
• Lower Silesia Cardiogenic Shock InitiativeRecruitingNCT05465200
• The Current Status and Clinical OUTcomes of Cardiogenic Shock Patients And the Role of Specialist in Cardiovascular Critical Care UnitRecruitingNCT05415332
• Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical TrialRecruitingNCT05366452Not applicable
• Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic ShockRecruitingNCT05298124Not applicable
• CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic ShockRecruitingNCT05267886Phase 4
• Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic ShockRecruitingNCT05185492
• ExtraCorporeal Membrane Oxygenation in the Therapy for REfractory Septic Shock With Cardiac Function Under EstimatedRecruitingNCT05184296Not applicable
• Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial InfarctionRecruitingNCT05168462Phase 4
• CytOSorb TreatMent Of Critically Ill PatientS RegistryRecruitingNCT05146336
• Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock PatientsNot yet recruitingNCT05106491Not applicable
• Unloading in Heart Failure Cardiogenic ShockNot yet recruitingNCT05064202Not applicable
• IABP In AMI Patients With SCAI-B StudyNot yet recruitingNCT04989777Not applicable
• Cardiogenic Shock Working Group RegistryRecruitingNCT04682483
• Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock TrialRecruitingNCT04419480Not applicable
• Outcome of Patients Treated With IABPRecruitingNCT04405856
• Outcome of Patients Treated With ECLSRecruitingNCT04405817
• Post-Surgery Extracorporeal Life SupportRecruitingNCT04330651
• Cardiogenic Shock Integrated PHenotyping for Event ReductionRecruitingNCT04323371
• Altshock-2 REGISTRYRecruitingNCT04295252
• Assessment of ECMO in Acute Myocardial Infarction Cardiogenic ShockRecruitingNCT04184635Not applicable
• China Extracorporeal Life Support RegistryRecruitingNCT04158479
• CARDSUP - SWISS Circulatory Support RegistryRecruitingNCT04117230
• Outcomes of Patients With Venoarterial Extracorporeal Membrane OxygenationRecruitingNCT04039594
• Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic ShockRecruitingNCT04020263Phase 3
• Hemoperfusion in Extracorporeal Membrane Oxygenation (ECMO) PatientsRecruitingNCT03729765Not applicable
• Inova Cardiogenic Shock Registry (INOVA SHOCK)RecruitingNCT03378739
• SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCKRecruitingNCT03313687
• Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.CompletedNCT05102734Results posted
• Early Insertion of Axillary Impella® With VA ECMOTerminatedNCT04084015Not applicableResults posted
• National Cardiogenic Shock InitiativeCompletedNCT03677180Results posted
• Impella CP With VA ECMO for Cardiogenic ShockTerminatedNCT03431467Not applicableResults posted
• Cardiogenic Shock Intravascular Cooling TrialCompletedNCT03141255Not applicableResults posted
• Synchronized Cardiac Assist for Cardiogenic ShockCompletedNCT02697006Results posted
• Anti-inflammatory Effect of Therapeutic Hypothermia in Out-hospital Cardiac Arrest Patients With Cardiogenic ShockCompletedNCT02633358Not applicableResults posted
• HEROIC (Heparin Requirement in Counterpulsation)TerminatedNCT00445211Phase 2Results posted
• Effect of Early Empagliflozin Initiation in Cardiogenic Shock.Active, not recruitingNCT07450417
• Prognostic Impact of Frailty in Cardiogenic ShockCompletedNCT07260084
• Effect of Mild Therapeutic Hypothermia on the Doses of Vasopressors and Inotropes in Cardiogenic Shock Complicating Acute Myocardial InfarctionCompletedNCT06947616Not applicable
• Left Ventricular Outflow Tract Mean Velocity in Children: a Strong Alternative to Cardiac Index in Pediatric Intensive Care UnitCompletedNCT06837727
• Augmented Pacing for Shock in the Cardiac Intensive Care UnitActive, not recruitingNCT06713668Not applicable
• Clinical Outcomes of Contemporary IMPELLA Devices in Cardiogenic Shock and High-risk Percutaneous Coronary InterventionActive, not recruitingNCT06690567
• Platelet Function and Impella SupportCompletedNCT06487091
• Shock and Acute Conditions OutcOmes PlatformActive, not recruitingNCT06376318
• Effect of Peripheral VA-ECMO Flow Variations on the Pulmonary Arterial Occlusion Pressure (PAPO) in Patients With Refractory Cardiogenic Shock.CompletedNCT06250439Not applicable
• Impella in Cardiogenic Shock RegistryStatus unknownNCT06007963
• Influence of Enteral Microbiome on Mortality of Patients With Cardiogenic ShockCompletedNCT06006754
• A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage CActive, not recruitingNCT05975021Phase 1/2
• Cardiovascular Magnetic Resonance Prognosticators in Pediatric Oncology Patients With SepsisCompletedNCT05930418Not applicable
• Impella Real-World Surveillance of Patients Using Sodium BicarbonateCompletedNCT05820451
• Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic ShockActive, not recruitingNCT05800951
• REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)CompletedNCT05788211
• Awake Axillary Impella 5.5 Placement - A Feasibility TrialWithdrawnNCT05782491Not applicable
• Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection RateCompletedNCT05750576Not applicable
• Efficacy and Clinical Outcomes of Levosimendan in E-CPRStatus unknownNCT05730907
• Comparison of Four Intensive Care Scores in Prediction of VA-ECMO Survival.Status unknownNCT05730881
• Evaluation of the 1-year Prognosis of Patients Under Veno-arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock With Blood Transfusion RequirementStatus unknownNCT05696210
• Digital Ischemia Reduction in Critically Ill PatientsWithdrawnNCT05661773Not applicable
• Establishing Physiologic Outcomes for Ventricular Unloading on VA ECMOWithdrawnNCT05658276
• The Effects of oXiris in Cardiogenic Shock Requiring VA-ECMOCompletedNCT05642273Not applicable
• The Nanowear Wearable System SimpleSense Validation Trial for Cardiac OutputTerminatedNCT05629533
• Ivabradine Effects in Cardiogenic Shock Requiring Inotropic SupportStatus unknownNCT05594342Phase 3
• Cardiogenic Shock Registry MannheimStatus unknownNCT05575856
• Score TO Predict SHOCK - STOP SHOCKStatus unknownNCT05570864
• The RECOVER IV TrialTerminatedNCT05506449Not applicable
• Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic ShockCompletedNCT05426083
• Management of Acute Cardiogenic Shock at the New Brunswick Heart CentreCompletedNCT05414643
• Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic ShockActive, not recruitingNCT05350592Phase 2
• Evaluation of eCPR SurvivorsStatus unknownNCT05339854
• Quality of Care in Centers Providing Extracorporeal Membrane OxygenationStatus unknownNCT05331001
• Outcomes in CArdiogenic SHock Patients Treated by MEchanical Circulatory suppoRt devicE : Impact of Shock TeamCompletedNCT05309980
• Volume Responsiveness By Ultrasound Of Carotid Blood Flow In Patients With Cardiogenic ShockCompletedNCT05271227
• LATIN SHOCK: Latin American Registry of Cardiogenic Shock in the Context of Acute Coronary SyndromeStatus unknownNCT05246683
• ECMELLA vs. ECMO on 30-day MortalityStatus unknownNCT05175898
• SURPASS Impella 5.5 StudyCompletedNCT05100836
• Innovative Technologies for the Treatment of Pulmonary and Heart FailureStatus unknownNCT05090930Not applicable
• ECMOsorb Trial - Impact of a VA-ECMO in Combination With CytoSorb in Critically Ill Patients With Cardiogenic ShockCompletedNCT05027529Not applicable
• Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic ShockCompletedNCT04990349Phase 3
• Carolinas Cardiogenic Shock InitiativeCompletedNCT04985708
• Passive Leg Raising for Predicting Fluid Responsiveness in VA-ECMO Assisted PatientsStatus unknownNCT04984603
• Safety Profile of the Combination of Levosimendan and IV Beta Blocker in Cardiogenic Shock: a Retrospective StudyStatus unknownNCT04938375
• Venous Oxygen Saturation During ECMO SupportCompletedNCT04934566Not applicable
• Closed Loop Mechanical Ventilation and ECMOCompletedNCT04925518Not applicable
• Levosimendan Infusion in Critically Ill Patients With Cardiogenic ShockCompletedNCT04917497
• Viability of Pulsioflex Monitoring in ICUCompletedNCT04911985
• Cytokine Hemoadsorption in ECMO PatientsCompletedNCT04901338
• Evaluation of Oxiris Membrane as a Treatment for Ischemia-reperfusion Syndrome in Cardiogenic Shock Treated With Extracorporeal Life Support (ECMO/ECLS): A Randomized Pilot Study ECMORIXCompletedNCT04886180Not applicable
• Incorporating Supersaturated Oxygen in ShockWithdrawnNCT04876040Not applicable
• Scoring Model for Predicting Outcome in Patients With Cardiogenic ShockStatus unknownNCT04850248
• Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane OxygenationCompletedNCT04775472Not applicable
• LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock PatientsCompletedNCT04728932Phase 3
• Feasibility and Safety of Total Percutaneous Closure of Femoral Arterial Access Sites in the Veno-arterial ECMO PatientsStatus unknownNCT04689451
• Validity of Cardiac Output Measurement Using Niccomo Device After Cardiac SurgeryStatus unknownNCT04643509
• Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Cardiogenic ShockCompletedNCT04642768Not applicable
• Cangrelor in Patients With Acute Myocardial Infarction Undergoing PCI After CPR, Ventilated or Cardiogenic ShockCompletedNCT04611607
• Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CPStatus unknownNCT04562272Not applicable
• Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)CompletedNCT04548739
• ECLS Versus IMPELLA™ as Bridge to LVAD (ECI-BLAD)CompletedNCT04480151
• Pressure Volume LoopStatus unknownNCT04478188
• Prospective Register on the Etiologies of Cardiogenic Shock and Their Prognosis at One Year.Status unknownNCT04467294

← Shock, Cardiogenic overview